Pharma Focus Europe
lonza-advanced-synthesis-logo
lonza-advanced-drug-development-banner lonza-advanced-drug-development-sm-banner

Small Molecules, Bioconjugates, and Precision Formulations

Our connected experts provide comprehensive contract development and manufacturing services that drive innovation across small molecules, advanced bioconjugates, and complex formulations. From early design to clinical and commercial supply, we accelerate progress — as one trusted partner.

A Single CDMO Partner

Whether you are developing a pioneering therapy or creating a new oral solid dosage form, we are the only CDMO partner you need. We seamlessly advance to market, as one.

100+ Years' Experience

Built on the spirit of collaboration, thousands of experts are working on life-saving products, from the very moment of discovery through to final treatments. We provide experience you can trust.

450 Molecules per Year

We are problem solving, advancing your most challenging molecules and bring life-changing answers to the most complex questions. We have helped develop and manufacture more than 450 molecules.

Check out these related White Papers

Novel ADC

Process Development for Antibody-Oligonucleotide Conjugates

Explore how Lonza’s experts are advancing bioconjugate science — enabling new therapeutic possibilities ...

Precision in miniature

Optimizing Multiparticulate Formulations for Pediatric Oncology

Developing medicines for children requires unique formulation strategies...

Better, faster small-molecule synthesis

Leveraging Modern Tools to Optimize Process Chemistry

Lonza’s Advanced Synthesis platform combines AI, high-throughput experimentation, and model-based design ...